Elevated matrix metalloproteinase‐9 levels in neuronal extracellular vesicles in Alzheimer’s disease
Abstract Objective This study aimed to investigate plasma neuronally derived extracellular vesicle (NDEV) levels of core pathological markers [amyloid‐β (Aβ) and phosphorylated tau] and inflammatory biomarkers, including interleukin 6 (IL‐6) and matrix metalloproteinase‐9 (MMP‐9) in patients with Al...
Main Authors: | Dongmei Gu, Fang Liu, Meng Meng, Liling Zhang, Marc L. Gordon, Ying Wang, Li Cai, Nan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | Annals of Clinical and Translational Neurology |
Online Access: | https://doi.org/10.1002/acn3.51155 |
Similar Items
-
A Journey on Extracellular Vesicles for Matrix Metalloproteinases: A Mechanistic Perspective
by: Sylvie Thuault, et al.
Published: (2022-05-01) -
Agonist-Biased Signaling via Matrix Metalloproteinase-9 Promotes Extracellular Matrix Remodeling
by: Bessi Qorri, et al.
Published: (2018-08-01) -
Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
by: Flavia Mariana Valente, et al.
Published: (2020-03-01) -
Matrix metalloproteinases 3 and 9 and loss of perineuronal nets in Alzheimer's disease
by: Baig, S, et al.
Published: (2006) -
Regulation of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in Abdominal Aortic Aneurysm
by: Shuo Wang, et al.
Published: (2023-09-01)